GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Santen Pharmaceutical Co Ltd (TSE:4536) » Definitions » Shiller PE Ratio

Santen Pharmaceutical Co (TSE:4536) Shiller PE Ratio : 25.40 (As of May. 17, 2024)


View and export this data going back to 1964. Start your Free Trial

What is Santen Pharmaceutical Co Shiller PE Ratio?

As of today (2024-05-17), Santen Pharmaceutical Co's current share price is 円1603.50. Santen Pharmaceutical Co's E10 for the quarter that ended in Mar. 2024 was 円63.14. Santen Pharmaceutical Co's Shiller PE Ratio for today is 25.40.

The historical rank and industry rank for Santen Pharmaceutical Co's Shiller PE Ratio or its related term are showing as below:

TSE:4536' s Shiller PE Ratio Range Over the Past 10 Years
Min: 14.41   Med: 25.2   Max: 45.65
Current: 26.1

During the past years, Santen Pharmaceutical Co's highest Shiller PE Ratio was 45.65. The lowest was 14.41. And the median was 25.20.

TSE:4536's Shiller PE Ratio is ranked worse than
52.53% of 533 companies
in the Drug Manufacturers industry
Industry Median: 25.16 vs TSE:4536: 26.10

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Santen Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2024 was 円0.320. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is 円63.14 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Santen Pharmaceutical Co Shiller PE Ratio Historical Data

The historical data trend for Santen Pharmaceutical Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Santen Pharmaceutical Co Shiller PE Ratio Chart

Santen Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.32 24.40 18.65 19.00 24.07

Santen Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.00 20.02 21.68 21.94 24.07

Competitive Comparison of Santen Pharmaceutical Co's Shiller PE Ratio

For the Drug Manufacturers - General subindustry, Santen Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Santen Pharmaceutical Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Santen Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Santen Pharmaceutical Co's Shiller PE Ratio falls into.



Santen Pharmaceutical Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Santen Pharmaceutical Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=1603.50/63.14
=25.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Santen Pharmaceutical Co's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Santen Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.32/107.2000*107.2000
=0.320

Current CPI (Mar. 2024) = 107.2000.

Santen Pharmaceutical Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 9.810 98.000 10.731
201409 13.730 98.500 14.943
201412 18.080 97.900 19.798
201503 16.300 97.900 17.848
201506 18.150 98.400 19.773
201509 86.900 98.500 94.575
201512 14.990 98.100 16.381
201603 8.370 97.900 9.165
201606 17.610 98.100 19.244
201609 12.480 98.000 13.652
201612 11.400 98.400 12.420
201703 11.230 98.100 12.272
201706 22.120 98.500 24.074
201709 15.300 98.800 16.601
201712 29.600 99.400 31.923
201803 19.400 99.200 20.965
201806 16.790 99.200 18.144
201809 18.440 99.900 19.787
201812 22.030 99.700 23.687
201903 21.170 99.700 22.763
201906 15.990 99.800 17.176
201909 16.860 100.100 18.056
201912 17.860 100.500 19.051
202003 8.300 100.300 8.871
202006 15.460 99.900 16.590
202009 19.040 99.900 20.431
202012 17.940 99.300 19.367
202103 -29.260 99.900 -31.398
202106 18.340 99.500 19.759
202109 17.390 100.100 18.623
202112 12.590 100.100 13.483
202203 19.650 101.100 20.836
202206 16.770 101.800 17.660
202209 -75.560 103.100 -78.565
202212 15.460 104.100 15.920
202303 2.530 104.400 2.598
202306 27.850 105.200 28.379
202309 24.520 106.200 24.751
202312 20.660 106.800 20.737
202403 0.320 107.200 0.320

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Santen Pharmaceutical Co  (TSE:4536) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Santen Pharmaceutical Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Santen Pharmaceutical Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Santen Pharmaceutical Co (TSE:4536) Business Description

Traded in Other Exchanges
Address
Grand Front Osaka Tower A, 4-20 Ofuka-cho, Kita-ku, Osaka, JPN, 530-8552
Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. The company reports two primary operating segments: prescription ophthalmic pharmaceuticals and other. The pharmaceuticals segment includes over-the-counter pharmaceuticals, while the other segment includes medical devices. The vast majority of Santen's revenue is derived from its prescription ophthalmic pharmaceuticals segment, which manufactures and distributes prescription and OTC pharmaceuticals. Most of Santen's sales are generated in Japan, followed by other Asian countries.

Santen Pharmaceutical Co (TSE:4536) Headlines

No Headlines